Camp4 Therapeutics Corp SEC filings CAMP
Camp4 Therapeutics Corp has 192 filings in SEC EDGAR's recent list, going back to Sep 25, 2018. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 5, 2026 | — |
| 4 | Insider transaction | Sep 2, 2026 | Aug 31, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 31, 2026 | — |
| 4 | Insider transaction | Aug 31, 2026 | Aug 27, 2026 |
| 4 | Insider transaction | Aug 26, 2026 | Aug 24, 2026 |
| 4 | Insider transaction | Aug 21, 2026 | Aug 19, 2026 |
| 4 | Insider transaction | Aug 19, 2026 | Aug 19, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 19, 2026 | — |
| 144 | Notice of proposed sale | Aug 19, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 10, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 5, 2026 | — |
| 4 | Insider transaction | Aug 5, 2026 | Aug 3, 2026 |
| 4 | Insider transaction | Aug 5, 2026 | Aug 3, 2026 |
| 4 | Insider transaction | Aug 5, 2026 | Aug 3, 2026 |
| 4 | Insider transaction | Aug 5, 2026 | Aug 3, 2026 |
| 4 | Insider transaction | Aug 5, 2026 | Aug 3, 2026 |
| 4 | Insider transaction | Aug 5, 2026 | Aug 3, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| 4 | Insider transaction | Apr 3, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Apr 3, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Apr 3, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Apr 3, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Apr 3, 2026 | Apr 1, 2026 |
| 3 | Initial insider ownership | Apr 3, 2026 | Apr 1, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Mar 11, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 5, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 8, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Dec 23, 2025 | — |
| 4 | Insider transaction | Dec 22, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Dec 22, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Dec 22, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Dec 22, 2025 | Dec 11, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Dec 11, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 7, 2025 | — |
| 3 | Initial insider ownership | Oct 10, 2025 | Oct 1, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 7, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 1, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 17, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 16, 2025 | — |
| 4 | Insider transaction | Sep 15, 2025 | Sep 11, 2025 |
| 4 | Insider transaction | Sep 15, 2025 | Sep 11, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Sep 15, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Sep 11, 2025 | — |
| 4 | Insider transaction | Sep 11, 2025 | Sep 11, 2025 |
| 4 | Insider transaction | Sep 11, 2025 | Sep 11, 2025 |
| 4 | Insider transaction | Sep 11, 2025 | Sep 11, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Sep 11, 2025 | — |
| 4 | Insider transaction | Sep 11, 2025 | Sep 11, 2025 |
| 4 | Insider transaction | Sep 11, 2025 | Sep 11, 2025 |
| 4 | Insider transaction | Sep 11, 2025 | Sep 11, 2025 |
| 4 | Insider transaction | Jun 27, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 27, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 27, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 27, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 27, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 27, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 27, 2025 | Jun 25, 2025 |
| 4 | Insider transaction | Jun 27, 2025 | Jun 25, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 14, 2025 | — |
| 3/A | Form 3/a | Apr 11, 2025 | Mar 17, 2025 |
| 4 | Insider transaction | Apr 3, 2025 | Apr 1, 2025 |
| 4 | Insider transaction | Apr 3, 2025 | Apr 1, 2025 |
| 4 | Insider transaction | Apr 3, 2025 | Apr 1, 2025 |
| 4 | Insider transaction | Apr 3, 2025 | Apr 1, 2025 |
| 4 | Insider transaction | Mar 19, 2025 | Mar 17, 2025 |
| 4 | Insider transaction | Mar 19, 2025 | Mar 17, 2025 |
| 3 | Initial insider ownership | Mar 19, 2025 | Mar 17, 2025 |
| 3 | Initial insider ownership | Mar 19, 2025 | Mar 17, 2025 |
| SC 13G | Ownership over 5% (passive) | Oct 22, 2024 | — |
| SC 13D | Ownership over 5% (active) | Oct 22, 2024 | — |
| 4/A | Filing | Oct 22, 2024 | Oct 15, 2024 |
| 3/A | Filing | Oct 22, 2024 | Oct 15, 2024 |
| SC 13G | Ownership over 5% (passive) | Oct 22, 2024 | — |
| SC 13D | Ownership over 5% (active) | Oct 22, 2024 | — |
| SC 13D | Ownership over 5% (active) | Oct 22, 2024 | — |
| 4 | Insider transaction | Oct 17, 2024 | Oct 15, 2024 |
| 4 | Insider transaction | Oct 17, 2024 | Oct 15, 2024 |
| 4 | Insider transaction | Oct 17, 2024 | Oct 15, 2024 |
| 4 | Insider transaction | Oct 15, 2024 | Oct 15, 2024 |
| 4 | Insider transaction | Oct 15, 2024 | Oct 15, 2024 |
| 4 | Insider transaction | Oct 15, 2024 | Oct 15, 2024 |
| 4 | Insider transaction | Oct 15, 2024 | Oct 15, 2024 |
| 4 | Insider transaction | Oct 15, 2024 | Oct 15, 2024 |
| 4 | Insider transaction | Oct 15, 2024 | Oct 15, 2024 |
| 4 | Insider transaction | Oct 15, 2024 | Oct 15, 2024 |
| 3 | Initial insider ownership | Oct 15, 2024 | Oct 15, 2024 |
| 3 | Initial insider ownership | Oct 10, 2024 | Oct 10, 2024 |
| 3 | Initial insider ownership | Oct 10, 2024 | Oct 10, 2024 |
| 3 | Initial insider ownership | Oct 10, 2024 | Oct 10, 2024 |
| 3 | Initial insider ownership | Oct 10, 2024 | Oct 10, 2024 |
| 3 | Initial insider ownership | Oct 10, 2024 | Oct 10, 2024 |
| 3 | Initial insider ownership | Oct 10, 2024 | Oct 10, 2024 |
| 3 | Initial insider ownership | Oct 10, 2024 | Oct 10, 2024 |
| 3 | Initial insider ownership | Oct 10, 2024 | Oct 10, 2024 |
| 3 | Initial insider ownership | Oct 10, 2024 | Oct 10, 2024 |
| 3 | Initial insider ownership | Oct 10, 2024 | Oct 10, 2024 |
| 3 | Initial insider ownership | Oct 10, 2024 | Oct 10, 2024 |
| 3 | Initial insider ownership | Oct 10, 2024 | Oct 10, 2024 |
| 3 | Initial insider ownership | Oct 10, 2024 | Oct 10, 2024 |
| 3 | Initial insider ownership | Oct 10, 2024 | Oct 10, 2024 |
| 3 | Initial insider ownership | Oct 10, 2024 | Oct 10, 2024 |
| 3 | Initial insider ownership | Oct 10, 2024 | Oct 10, 2024 |
| 3 | Initial insider ownership | Oct 10, 2024 | Oct 10, 2024 |
| 3 | Initial insider ownership | Oct 10, 2024 | Oct 10, 2024 |
Showing 114 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CAMP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Watertown, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1736730
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.